Dr. Friedlaender received his BS (1967) and MD (1969) degrees from the University of Michigan and then spent two years as a house officer in general surgery at the University of Michigan Medical Center (1969-1971).His orthopaedic residency training occurred at Yale-New Haven Hospital and Newington Children’s Hospital (1971-1974).In 1976, after 2 years service in the U.S. Navy assigned to the Naval Medical Research Institute and the U.S. Navy Tissue Bank in Bethesda, Dr. Friedlaender joined the full-time faculty of Yale University School of Medicine (1976) and since 1986 has served as Professor and Chair of the Department of Orthopaedics and Rehabilitation.Dr. Friedlaender has also trained at Massachusetts General Hospital in musculoskeletal oncology, which remains his primary clinical and research interest.
Dr. Friedlaender has served as President of the American Association of Tissue Banks (1983-85), the American Council on Transplantation (1983-85), the Orthopaedic Research Society (1994-95), the Academic Orthopaedic Society (1995-96), the Association of Bone and Joint Surgeons (2001-02) and, in 2010, the American Orthopaedic Association.He has also chaired the American Academy of Orthopaedic Surgeon’s Council of Musculoskeletal Specialty Societies, Committee on Research, Committee on Academic Advocacy, Task Force on Tissue Banking and has served as a member of the Academy’s Board of Directors along with numerous other committee appointments related to research, education, communication, advocacy and ethics.In 2014, he received the AAOS Tipton Leadership Award.In 2002, Dr. Friedlaender was selected Orthopaedist-of-the-Year by the Connecticut Orthopaedic Society.
In the past, Dr. Friedlaender served as Chair of the National Arthritis Board, NIAMS (NIH), as a member of the Orthopaedic Study Section at NIH and was a member of the Advisory Council of NIAMS.He has also served as a panel member for the Food and Drug Administration (FDA). Dr. Friedlaender served or serves on the editorial boards of several journals, including the Journal of Bone and Joint Surgery, Clinical Orthopaedics and Related Research, Spine, Journal of Orthopaedic Research and the Journal of the American Academy of Orthopaedic Surgeons; and he has written numerous scientific publications and received national awards for his basic science and translational research (Kappa Delta Award of the American Academy of Orthopaedic Surgery and the Nicholas Andry Award of the Association of Bone and Joint Surgeons).
Dr. Friedlaender is a scientific consultant for Wright Medical Group and is compensated for these services.
- Bone Neoplasms
- Soft Tissue Neoplasms
Accepts new patients? Yes
Patient Type: Adult; Adolescent; Child; Geriatric
Referrals: From patients or physicians